Stocks and Investing Stocks and Investing
Thu, March 17, 2022
[ 12:00 AM ] - United States, WOPRAI
John Walsh Maintained (AYI) at Buy with Decreased Target to $241 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Constantine Davides Maintained (BIVI) at Strong B .. with Increased Target to $140 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sarang Vora Maintained (BRCC) at Buy with Increased Target to $20 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Liam Burke Initiated (AE) at Strong Buy and Held Target at $45 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brent Thill Maintained (ADBE) at Strong Buy with Decreased Target to $550 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Andrew Berens Downgraded (BGNE) to Hold and Decreased Target to $177 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bryan Bergin Maintained (ACN) at Buy with Increased Target to $375 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Grossman Maintained (ACN) at Strong Buy with Decreased Target to $368 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Moshe Katri Maintained (ACN) at Buy with Decreased Target to $350 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Geoff Meacham Maintained (ABBV) at Hold with Increased Target to $152 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Reni Benjamin Maintained (ACET) at Buy with Decreased Target to $21 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Alexander Hacking Maintained (AA) at Strong Buy with Increased Target to $84 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jonathan Ruykhaver Maintained (ZS) at Buy with Decreased Target to $300 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Steve Moss Downgraded (ZION) to Hold on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Thomas Champion Maintained (ZG) at Hold with Decreased Target to $57 on, Mar 17th, 2022
[ 12:00 AM ] - United States, WOPRAI
Thomas Champion Maintained (Z) at Hold with Decreased Target to $57 on, Mar 17th, 2022
Wed, March 16, 2022
[ 12:00 AM ] - United States, WOPRAI
Fawne Jiang Maintained (YY) at Strong Buy with Decreased Target to $62 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Sumant Kulkarni Upgraded (ACAD) to Strong Buy and Increased Target to $31 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Andrew Tsai Upgraded (BEKE) to Buy and Decreased Target to $16 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Adam Samuelson Maintained (BHIL) at Hold with Decreased Target to $210 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gregory Renza Maintained (APRE) at Hold with Decreased Target to $80 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Andrew Fein Maintained (APRE) at Hold with Decreased Target to $40 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Elliot Wilbur Maintained (ANIP) at Buy with Decreased Target to $47 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Donald Fandetti Maintained (AOMR) at Buy with Decreased Target to $21 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Parker Lane Maintained (ADBE) at Strong Buy with Decreased Target to $600 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ronald Epstein Maintained (BWXT) at Strong Buy with Increased Target to $65 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Kaumil Gajrawala Maintained (BRBR) at Hold with Decreased Target to $26 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gabriela Borges Maintained (BRZE) at Strong Buy with Decreased Target to $60 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
PJ Juvekar Maintained (BLDP) at Hold with Decreased Target to $11 on, Mar 16th, 2022
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Decreased Target to $22 on, Mar 16th, 2022

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Decreased Target to $22 on, Mar 16th, 2022


Published on 2024-10-27 20:06:35 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Decreased Target from $24 to $22 on, Mar 16th, 2022.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram

  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $18 on, Friday, March 11th, 2022
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $26 on, Wednesday, March 9th, 2022

Contributing Sources